LGND Ligand Pharmaceuticals Incorporated Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

LGND [NASD]

Ligand Pharmaceuticals Incorporated

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-3.44	Insider Own	4.10%	Shs Outstand	16.53M	Perf Week	0.27%
Market Cap	1.81B	Forward P/E	26.75	EPS next Y	4.19	Insider Trans	-3.74%	Shs Float	15.41M	Perf Month	-9.25%
Income	-61.20M	PEG	-	EPS next Q	0.76	Inst Own	-	Short Float	61.32%	Perf Quarter	35.18%
Sales	110.00M	P/S	16.41	EPS this Y	432.60%	Inst Trans	1.30%	Short Ratio	25.62	Perf Half Y	15.18%
Book/sh	40.04	P/B	2.80	EPS next Y	14.25%	ROA	-4.10%	Target Price	176.33	Perf Year	-6.62%
Cash/sh	47.96	P/C	2.34	EPS next 5Y	18.63%	ROE	-7.40%	52W Range	57.24 - 124.96	Perf YTD	7.59%
Dividend	-	P/FCF	-	EPS past 5Y	124.30%	ROI	45.50%	52W High	-10.21%	Beta	1.63
Dividend %	-	Quick Ratio	40.30	Sales past 5Y	13.30%	Gross Margin	88.90%	52W Low	96.03%	ATR	5.41
Employees	115	Current Ratio	40.60	Sales Q/Q	-23.70%	Oper. Margin	-14.20%	RSI (14)	50.20	Volatility	4.29% 5.03%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-104.70%	Profit Margin	-55.60%	Rel Volume	0.56	Prev Close	111.97
Shortable	Yes	LT Debt/Eq	0.67	Earnings	May 06 AMC	Payout	-	Avg Volume	368.93K	Price	112.21
Recom	2.20	SMA20	-0.19%	SMA50	4.03%	SMA200	11.91%	Volume	208,236	Change	0.21%

Mar-24-20

Downgrade

Argus

Buy → Hold

Mar-10-20

Initiated

Guggenheim

Neutral

Feb-06-20

Initiated

The Benchmark Company

Buy

$135

Sep-19-19

Upgrade

Barclays

Equal Weight → Overweight

$110 → $132

Jun-11-19

Initiated

Barclays

Equal Weight

$131

May-03-19

Reiterated

H.C. Wainwright

Buy

$254 → $214

Mar-06-19

Reiterated

H.C. Wainwright

Buy

$281 → $254

Oct-29-18

Upgrade

ROTH Capital

Neutral → Buy

Oct-02-18

Reiterated

H.C. Wainwright

Buy

$270 → $280

Sep-11-18

Reiterated

Argus

Buy

$260 → $300

Aug-17-18

Initiated

Goldman

Neutral

$256

Aug-08-18

Downgrade

ROTH Capital

Buy → Neutral

Jun-21-18

Initiated

Argus

Buy

$260

Dec-27-17

Reiterated

H.C. Wainwright

Buy

$163 → $169

Sep-05-17

Resumed

H.C. Wainwright

Buy

$150

Oct-05-16

Reiterated

H.C. Wainwright

Buy

$146 → $160

Aug-05-16

Downgrade

Deutsche Bank

Hold → Sell

$104 → $110

Mar-11-16

Initiated

Sidoti

Buy

Mar-03-16

Initiated

H.C. Wainwright

Buy

$146

Dec-18-15

Reiterated

ROTH Capital

Buy

$144 → $146

Jul-08-20 10:00AM	Sermonix Pharmaceuticals to Collaborate With Eli Lilly and Company in Studying Combination of Lasofoxifene and Lillys CDK 4 and 6 Inhibitor, Abemaciclib, in Metastatic Breast Cancer GlobeNewswire
Jul-03-20 11:40AM	LGND or RGEN: Which Is the Better Value Stock Right Now? Zacks
Jun-29-20 12:48PM	IPA Confirms Discovery of Fully Human, Potent, Neutralizing Antibodies Targeting SARS-CoV-2 CNW Group
11:44AM	Ascendis Submits BLA to FDA for TransConhGH in Pediatric GHD Zacks
09:12AM	Vertex's Triple Combo Cystic Fibrosis Pill Gets CHMP Backing Zacks
Jun-17-20 11:40AM	LGND or RGEN: Which Is the Better Value Stock Right Now? Zacks
Jun-15-20 08:30AM	Ligand Announces an Expansion of Vernalis Collaboration with Servier for Research on Novel Oncology Targets Business Wire
Jun-08-20 02:04PM	Hedge Funds Piling Into Ligand Pharmaceuticals Inc. (LGND) Again Insider Monkey
Jun-05-20 11:31AM	Why Is Ligand (LGND) Up 16.3% Since Last Earnings Report? Zacks
Jun-04-20 10:45PM	Edited Transcript of LGND earnings conference call or presentation 6-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-03-20 06:43PM	Ligand Pharmaceuticals Shows Improved Relative Price Performance; Still Shy Of Benchmark Investor's Business Daily +6.56%
Jun-01-20 04:53PM	Ligand CEO Issues Letter to Captisol Customers Business Wire
11:40AM	LGND or TECH: Which Is the Better Value Stock Right Now? Zacks
May-29-20 08:00AM	Ligand Announces Icagens Expansion of Collaboration with Roche to Develop and Commercialize Therapies for Neurological Diseases Business Wire
May-28-20 04:22PM	Ligand Earns $3 Million Milestone Payment from Palvella Therapeutics Business Wire
04:08PM	Palvella Therapeutics Completes $45 Million Series C Financing GlobeNewswire
May-22-20 08:58AM	Update: Ligand Pharmaceuticals (NASDAQ:LGND) Stock Gained 20% In The Last Five Years Simply Wall St.
May-14-20 11:50AM	Should Value Investors Buy Ligand Pharmaceuticals (LGND) Stock? Zacks
May-07-20 04:00PM	Ligand Pharmaceuticals Inc (LGND) Q1 2020 Earnings Call Transcript Motley Fool
11:40AM	LGND vs. TECH: Which Stock Should Value Investors Buy Now? Zacks
11:11AM	Ligand (LGND) Beats on Q1 Earnings & Sales, Raises View Zacks
May-06-20 05:45PM	Ligand Pharmaceuticals (LGND) Q1 Earnings and Revenues Beat Estimates Zacks
04:01PM	Ligand Reports First Quarter 2020 Financial Results Business Wire
May-03-20 03:37PM	A Potentially Undervalued Trio to Consider GuruFocus.com
Apr-29-20 12:34PM	Analysts Estimate Ligand Pharmaceuticals (LGND) to Report a Decline in Earnings: What to Look Out for Zacks +8.52%
Apr-22-20 08:30AM	Ligands First Quarter Financial Results to be Reported May 6th Business Wire
Apr-17-20 08:00AM	ImmunoPrecise Provides Updates on B Cell Select and Deep Display Programs for SARS-CoV-2 Antibody Discovery CNW Group +6.07%
Apr-09-20 10:51AM	Is the Options Market Predicting a Spike in Ligand (LGND) Stock? Zacks
Apr-08-20 12:10PM	Hedge Funds Are Betting On Ligand Pharmaceuticals Inc. (LGND) Insider Monkey +6.11%
Apr-07-20 12:16PM	Should You Take Comfort From Insider Transactions At Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)? Simply Wall St.
Apr-06-20 07:00AM	Ligand Provides a Corporate Update and Announces May 6th as the Date for First Quarter Earnings Call Business Wire +5.75%
Apr-02-20 04:02PM	Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs and Ion Channel Technologies Business Wire +5.37%
Mar-18-20 02:29PM	Top Biotech Stocks for Q2 2020 Investopedia
Mar-10-20 08:00AM	Ligands Presentation at the Barclays Global Healthcare Conference Now a Webcast Only, New Slides Available on Ligand.com Business Wire
Mar-09-20 01:30PM	6 Cheap Health Care Stocks GuruFocus.com -12.03%
Mar-07-20 11:30AM	Ligand (LGND) Up 16.3% Since Last Earnings Report: Can It Continue? Zacks
Mar-02-20 08:00AM	Ligand Pharmaceuticals Management to Present at Two Investor Conferences in March Business Wire +9.82%
Feb-27-20 08:00AM	Ligand Raises 2020 Financial Guidance Due to Higher Captisol Material Sales Business Wire
Feb-19-20 08:00PM	INVESTOR ALERT: BDX LGND LOPE SBT: Kirby McInerney LLP Continues Investigation of Shareholder Claims GlobeNewswire
06:30AM	Hedge Fund Alleges SEC Bias in Short-Selling Case Barrons.com
Feb-17-20 11:12AM	Edited Transcript of LGND earnings conference call or presentation 6-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-11-20 04:14PM	Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen Business Wire
Feb-07-20 10:49AM	Ligand (LGND) Q4 Earnings & Revenues Top Estimates, Stock Up Zacks
Feb-06-20 06:35PM	Ligand Pharmaceuticals (LGND) Surpasses Q4 Earnings and Revenue Estimates Zacks
04:01PM	Ligand Reports Fourth Quarter and Full Year 2019 Financial Results Business Wire
Feb-03-20 08:30AM	Ligand's Technologies Support and Enable Potential Coronavirus Treatments Business Wire
Jan-13-20 04:02PM	Ligand Enters into OmniAb® Platform License Agreement with Pandion Therapeutics Business Wire
Jan-09-20 02:47PM	Ligand to Report 2019 Fourth Quarter and Full Year Financial Results on February 6th Business Wire
Jan-08-20 11:04AM	Does Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Have A High Beta? Simply Wall St.
Jan-06-20 11:40AM	LGND vs. ALKS: Which Stock Is the Better Value Option? Zacks
Dec-23-19 08:30AM	Two Ligand Pharmaceuticals Board Members Recognized as 2019 Most Influential Corporate Directors by WomenInc. Magazine Business Wire
Dec-20-19 05:03PM	Is Ligand Pharmaceuticals Inc. (LGND) A Good Stock To Buy ? Insider Monkey
Dec-12-19 10:41PM	Top stock picks for 2020: Making money with midsize firms MarketWatch
Dec-06-19 08:00AM	12 Biotech Stocks Primed For A Short Squeeze Benzinga
Dec-05-19 11:31AM	Why Is Ligand (LGND) Up 5.3% Since Last Earnings Report? Zacks
Dec-02-19 08:30AM	Ligand Enters into Worldwide OmniAb® Platform License Agreement with Sanofi Business Wire
Nov-19-19 07:16AM	Edited Transcript of LGND earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-12-19 08:30AM	Ligand Pharmaceuticals Ranked in Deloittes 2019 Technology Fast 500 Business Wire
Nov-08-19 08:30AM	Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol Business Wire +7.06%
Nov-07-19 08:30AM	Ligand to Participate in the Stephens 2019 Nashville Investment Conference Business Wire
Nov-06-19 09:33AM	Ligand's (LGND) Q3 Earnings Miss Estimates, EPS View Down Zacks -8.57%
Nov-05-19 06:15PM	Ligand Pharmaceuticals (LGND) Q3 Earnings Miss Estimates Zacks
04:02PM	Talem Therapeutics accesses the OmniAb® platform from Ligand Pharmaceuticals CNW Group
04:01PM	Ligand Reports Third Quarter 2019 Financial Results Business Wire
Oct-29-19 10:32AM	Analysts Estimate Ligand Pharmaceuticals (LGND) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-25-19 10:13AM	Is Ligand Pharmaceuticals Inc. (LGND) Going To Burn These Hedge Funds ? Insider Monkey
Oct-22-19 04:01PM	Ligand to Report Third Quarter 2019 Results on November 5th Business Wire
Oct-15-19 09:00AM	Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors Business Wire
Oct-10-19 10:08AM	Who Has Been Buying Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares? Simply Wall St.
Oct-03-19 08:00AM	ImmunoPrecise Strengthens Board of Directors with Antibody Business Leader, Brian Lundstrom CNW Group +5.03%
Sep-23-19 10:01AM	Sermonix Doses First Patient in Phase 2 Clinical Trial of Lasofoxifene for Targeted Precision Medicine Treatment of Women With ESR1 Mutations in Metastatic Breast Cancer GlobeNewswire
Sep-13-19 08:42AM	Ligand (LGND) Surges: Stock Moves 6.3% Higher Zacks
Sep-12-19 06:41AM	Ligand Pharmaceuticals approves new $500 million stock buyback program MarketWatch +6.26%
Aug-29-19 09:31AM	Why Is Ligand (LGND) Down 0.9% Since Last Earnings Report? Zacks
09:00AM	Ligand to Participate in the H. C. Wainwright 21st Annual Global Investment Conference Business Wire
Aug-23-19 07:38AM	Retrophin Down on Neurological Disorder Drug Study Failure Zacks
Aug-14-19 06:15PM	3 Top Biotech Stocks to Buy in August Motley Fool
Aug-12-19 09:00AM	Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China Business Wire
Aug-03-19 08:51AM	Edited Transcript of LGND earnings conference call or presentation 30-Jul-19 1:00pm GMT Thomson Reuters StreetEvents
Jul-31-19 09:15PM	Ligand Pharmaceuticals Inc (LGND) CEO John L Higgins Bought $176,582 of Shares GuruFocus.com
10:44AM	Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat Zacks
Jul-30-19 06:09PM	Ligand Pharmaceuticals Incorporated (LGND) Q2 2019 Earnings Call Transcript Motley Fool -11.38%
01:32PM	Long-Time Ligand Short Increases Position As Shares Fall 11% On Earnings Benzinga
09:25AM	Ligand Pharmaceuticals (LGND) Surpasses Q2 Earnings and Revenue Estimates Zacks
08:00AM	Ligand Reports Second Quarter 2019 Financial Results Business Wire
Jul-23-19 04:15PM	Ligand Acquires Ab Initio Biotherapeutics, an Antigen-Discovery Company Business Wire
10:32AM	Analysts Estimate Ligand Pharmaceuticals (LGND) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-17-19 01:49PM	Andrew Left's Citron Capital posted net return of 24.7% in 1st half of 2019 Reuters
Jul-16-19 11:19AM	Lemelson Capital Management Announces 1H, 2019 Financial Results for The Amvona Fund, LP PR Newswire
Jul-15-19 09:00AM	Ligand to Report Second Quarter 2019 Results on July 30th Business Wire
Jul-12-19 07:36AM	Is Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Expensive For A Reason? A Look At Its Intrinsic Value Simply Wall St.
Jul-10-19 09:00AM	Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol Business Wire
Jul-08-19 08:30AM	Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol® License and Supply Agreements for High-Concentration Furosemide Formulation PR Newswire
Jul-01-19 09:00AM	ZULRESSO (brexanolone) CIV, a Product for Treating Postpartum Depression Using Ligands Captisol® in its Formulation, Launched by Sage Therapeutics Business Wire
Jun-20-19 02:52PM	What does Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Balance Sheet Tell Us About Its Future? Simply Wall St.
Jun-13-19 09:36AM	Ligand Inks Oncology Drug Discovery Deal With PhoreMost Zacks
Jun-12-19 09:00AM	Ligand Subsidiary Vernalis and PhoreMost Limited Announce Drug Discovery Collaboration for Novel Oncology Target Business Wire
Jun-10-19 01:54PM	Is Ligand Pharmaceuticals Inc. (LGND) A Good Stock To Buy? Insider Monkey
Jun-03-19 11:52AM	Should You Worry About Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) CEO Salary Level? Simply Wall St.
May-31-19 09:15PM	Ligand Pharmaceuticals Inc (LGND) CEO John L Higgins Bought $108,200 of Shares GuruFocus.com

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. The company's commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis and Evomela, which are used to treat multiple myeloma; Baxdela, a captisol-enabled delafloxacin-IV for the treatment of acute bacterial skin and skin structure infections; Nexterone, a captisol-enabled formulation of amiodarone; Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; and Carnexiv, which is indicated as replacement therapy for oral carbamazepine formulations. It also offers bazedoxifene for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Minnebro for the treatment of hypertension; and Bryxta for non-small cell lung cancer. The company's partners programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney, and other diseases. It is also developing a small molecule glucagon receptor antagonist for the treatment of Type 2 diabetes mellitus. In addition, the company is involved in the sale of Captisol materials. Ligand Pharmaceuticals Incorporated was founded in 1987 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HIGGINS JOHN L	Chief Executive Officer	Jul 07	Option Exercise	70.01	4,315	302,098	204,571	Jul 09 04:28 PM
Berkman Charles S	SVP, Gen. Counsel & Secretary	Jun 04	Sale	118.59	11,146	1,321,775	40,877	Jun 05 04:07 PM
FOEHR MATTHEW W	President and COO	Mar 13	Option Exercise	21.92	2,000	43,840	157,449	Mar 13 06:33 PM
FOEHR MATTHEW W	President and COO	Feb 27	Option Exercise	15.89	8,931	141,941	160,968	Feb 27 08:35 PM
FOEHR MATTHEW W	President and COO	Feb 27	Sale	110.00	7,225	794,750	153,743	Feb 27 08:35 PM
FOEHR MATTHEW W	President and COO	Feb 14	Option Exercise	14.47	7,225	104,546	163,454	Feb 18 05:09 PM
FOEHR MATTHEW W	President and COO	Feb 14	Sale	95.84	7,225	692,467	156,229	Feb 18 05:09 PM
HIGGINS JOHN L	Chief Executive Officer	Feb 13	Option Exercise	9.96	48,125	479,325	201,739	Feb 18 05:11 PM
FOEHR MATTHEW W	President and COO	Feb 13	Option Exercise	21.92	496	10,872	148,833	Feb 18 05:09 PM
FOEHR MATTHEW W	President and COO	Nov 12	Option Exercise	21.92	1,001	21,942	144,620	Nov 13 04:07 PM
FOEHR MATTHEW W	President and COO	Sep 05	Option Exercise	21.92	1,005	22,030	143,619	Sep 05 07:24 PM
Aryeh Jason	Director	Sep 03	Buy	87.01	750	65,258	67,203	Sep 04 07:30 PM
Korenberg Matthew E	EVP,Finance & Strategy and CFO	Sep 03	Buy	86.18	500	43,091	17,151	Sep 03 07:34 PM
FOEHR MATTHEW W	President and COO	Aug 12	Option Exercise	21.92	1,163	25,493	142,614	Aug 13 01:45 PM
Berkman Charles S	SVP, Gen. Counsel & Secretary	Aug 05	Option Exercise	67.72	1,093	74,013	47,172	Aug 06 05:17 PM
Aryeh Jason	Director	Aug 05	Buy	90.01	746	67,146	66,453	Aug 06 05:18 PM
Patel Sunil	Director	Aug 02	Buy	95.98	1,000	95,980	26,359	Aug 05 06:56 PM
Davis Todd C	Director	Aug 02	Buy	93.59	1,000	93,594	49,474	Aug 05 07:04 PM
LAMATTINA JOHN L	Director	Aug 01	Option Exercise	32.30	2,500	80,750	24,784	Aug 05 07:00 PM
HIGGINS JOHN L	Chief Executive Officer	Jul 31	Buy	95.45	1,850	176,583	146,749	Jul 31 07:26 PM
Aryeh Jason	Director	Jul 31	Buy	93.00	754	70,122	65,707	Jul 31 06:50 PM
Sabba Stephen L	Director	Jul 31	Sale	94.45	4,091	386,395	23,600	Aug 01 02:49 PM
Aryeh Jason	Director	Jul 30	Buy	100.22	3,000	300,663	64,953	Jul 31 06:50 PM
Aryeh Jason	Director	Jul 29	Buy	106.01	250	26,503	61,953	Jul 31 06:50 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience